北京市鲁谷社区卫生服务中心应用抗骨质疏松药物的合理性分析  

Analysis of Utilization of Anti-osteoporosis Drugs in Lugu Community Health Service Center of Beijing

作　　者：吴华[1] 谷清[1] 

机构地区：[1]首都医科大学附属北京朝阳医院西区药事办,北京100043

出　　处：《中国药房》2015年第12期1648-1650,共3页China Pharmacy

摘　　要：目的:促进北京市鲁谷社区合理应用抗骨质疏松药物。方法:以药物的销售金额、用药频度(DDDs)及日均费用(DDC)为指标对鲁谷社区卫生服务中心(以下简称我中心)2012年7月-2013年6月与2013年7月-2014年6月抗骨质疏松药物使用情况进行回顾性分析。结果:我中心抗骨质疏松药物销售金额逐年上涨,占药物总销售金额比例也有所增长。主要品种为钙制剂类、维生素D类、双膦酸盐类和中成药类,其中中成药的销售金额所占比例较大,2年间基本持平;碳酸钙D3片的销售金额所占比例和DDDs最高;骨化三醇胶丸、骨疏康胶囊和骨康胶囊的DDC较高。结论:中成药用于治疗骨质疏松症,因缺乏大型的临床研究证据,应慎重选择。目前,我中心抗骨质疏松药物用药品种较单一,与社区医院的抗骨质疏松药物品种有限以及社区医务人员对骨质疏松症相关知识知晓率低有关。应增强对骨质疏松症的重视,通过培训提高医务人员和患者对相关知识的知晓率。OBJECTIVE：To evaluate the rational use of anti-osteoporosis drugs in Lugu community health service center（CHSC）. METHODS：With the indexes of sales amount,DDDs and DDC,the use of anti-osteoporosis drugs in Lugu CHSC of Jul. 2012-Jun. 2013 and Jul. 2013-Jun. 2014 was retrospectively analyzed. RESULTS：The sales amount and the proportion of them in total sales amount of anti-osteoporosis drugs in our center were all increased year by year. It was mainly calcium preparations,vitamin D,bisphosphonates and Chinese patent medicine. Among these,the sales amount of Chinese patent medicine had a large proportion,basically plat during 2 years;the proportion of sales amount and DDDs of Calcium carbonate D3 tablets was the highest;the DDC of Calcitriol soft gelatin capsule,Gushukang capsule and Gukang capsule were higher. CONCLUSIONS：Chinese patent medicine should be carefully used in the treatment of osteoporosis for a lack of large clinical studies. The variety of anti-osteoporosis drug is single in our center and it is related to the low awareness rate of osteoporosis relevant knowledge. The importance of osteoporosis should be enhanced by improving the awareness rate of relevant knowledge of medical staff and patients.

关 键 词：抗骨质疏松药物 销售金额 用药频度 日均费用 社区卫生服务中心 

分 类 号：R969.3[医药卫生—药理学]